Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
Showing 1 - 25 of >10,000
Influenza Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (A/Mallard/Ohio-99/MM4/1989
Not yet recruiting
- Influenza Infection
- A/Mallard/Ohio-99/MM4/1989 H10N7
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
enVista Toric 0.9D Intraocular Lenses
Recruiting
- Corneal Astigmatism
- enVista Toric
- enVista non-Toric (spherical)
-
Calgary, Alberta, Canada
- +2 more
Nov 9, 2022
![](/image/sponsor/federal_budgetary_research_institution_state_research_center_of_virology_and_biotechnology_"vector")
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,
Completed
- Smallpox
- +3 more
- NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
- +5 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023
Prostate Cancer Trial in Canada (PSMA PET/CT guided intensification of therapy, Control Arm)
Recruiting
- Prostate Cancer
- PSMA PET/CT guided intensification of therapy
- Control Arm
-
Kelowna, British Columbia, Canada
- +13 more
Dec 14, 2022
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Critical Illness Trial in Canada (Albumin Fluid Resuscitation Optimization Intervention, Usual Practice)
Completed
- Critical Illness
- Albumin Fluid Resuscitation Optimization Intervention
- Usual Practice
-
Calgary, Alberta, Canada
- +14 more
Oct 31, 2022
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
Neurologic Physiology After Removal of Therapy (NeuPaRT)
Not yet recruiting
- Determination of Death
- electroencephalography (EEG)
-
Calgary, Alberta, Canada
- +4 more
Aug 17, 2022
Low Back Disorder, Shoulder Disease, Musculoskeletal Injury Trial (Remote functional testing protocol)
Recruiting
- Low Back Disorder
- +2 more
- Remote functional testing protocol
-
London, Ontario, Canada
- +4 more
Nov 22, 2022
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
Chronic Heart Failure, Chronic Kidney Diseases Trial in Ottawa, Toronto (ODYSSEE-vCHAT)
Active, not recruiting
- Chronic Heart Failure
- Chronic Kidney Diseases
- ODYSSEE-vCHAT
-
Ottawa, Ontario, Canada
- +3 more
Jan 16, 2023
Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)
Recruiting
- Cystic Fibrosis Pulmonary Exacerbation
- Prednisone
- Placebos
-
Calgary, Alberta, Canada
- +11 more
Nov 23, 2022
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
Vasovagal Syncope Trial in Calgary (Atomoxetine Hydrochloride, Placebo)
Recruiting
- Vasovagal Syncope
- Atomoxetine Hydrochloride
- Placebo
-
Calgary, Alberta, CanadaUniversity of Calgary
Jun 28, 2022
Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)
Not yet recruiting
- Non-melanoma Skin Cancer
- +3 more
- Nicotinamide
- Placebo
-
Calgary, Alberta, Canada
- +7 more
Jul 13, 2023
Elagolix For the Treatment of Endometriosis in Canada
Completed
- Endometriosis
-
Calgary, Alberta, Canada
- +17 more
Sep 26, 2022